Press release
Imfinzi Market By Size, Demand Analysis, Type, Statistics, Regions and Forecast - 2028
The global imfinzi market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). Imfinzi is a human immunoglobulin G1 kappa monoclonal antibody that prevents programmed cell death ligand 1 from interacting with PD-1. Imfinzi is a checkpoint inhibitor medication. It is a prescription drug that is used to treat adults who have non-small cell lung cancer (NSCLC). The rising prevalence of urothelial carcinoma and lung cancer are the primary factors driving the imfinzi market globally.(Get 15% Discount on Buying this Report)
Get Sample Copy of Imfinzi at: https://orionmarketreports.com/request-sample/?id=103487&submit=Request+Sample%0D%0A
The market players are also contributing significantly to the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, in order to stay competitive in the market. For instance-
• In January 2022, the HIMALAYA Phase-III trial found that a single priming dose of tremelimumab added to imfinzi improved overall survival (OS) statistically significantly and clinically meaningfully compared to sorafenib as a first-line treatment for patients with unresectable hepatocellular carcinoma (HCC) who had not received prior systemic therapy and were not eligible for localized treatment.
• In November 2020, imfinzi from AstraZeneca has been approved in the US for an additional dosing option, in the approved indications of unresectable stage-III NSCLC after chemoradiation therapy (CRT) and previously treated advanced bladder cancer. This new option is compatible with approved imfinzi dosing in ES-SCLC and will be available for patients weighing more than 30kg as an alternative to the current weight-based dose of 10mg/kg every two weeks.
• In September 2020, based on the results of the "Pacific" clinical trial, the USFDA approved imfinizi for the treatment of patients with stage-III NSCLC whose cancer is unresectable and has not progressed after chemoradiation because adding imfinizi to chemoradiation further delayed cancer progression and prolonged survival. With the inclusion of imfinzi, 50% of unresectable stage-III NSCLC patients survive 4 years from treatment, a significant improvement over the previous standard of 15% to 20%.
• In November 2019, the USFDA approved a supplemental Biologics License Application (sBLA) and awarded imfinzi priority review for the treatment of patients with previously untreated extensive-stage small-cell lung cancer, as per the AstraZeneca (SCLC).
A full report of Global Imfinzi Market is available at: https://orionmarketreports.com/imfinzi-market/103487/
Market Coverage
• The market number available for - 2021-2028
• Base year- 2021
• Forecast period- 2022-2028
• Segment Covered-
o By Distribution Channel
• Regions Covered-
o North America
o Europe
o Asia-Pacific
o Rest of the World
• Competitive Landscape- AstraZeneca plc, among others.
Key questions addressed by the report
• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How has COVID-19 impacted the market?
o Deviation from the pre-COVID-19 forecast
o Most affected region and segment
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?
Global Imfinzi Market Report by Segment
By Distribution Channel
• Retail Pharmacy
• Hospital Pharmacy
• Others
Media Contact:
Company Name: Orion Market Reports
Contact Person: Mr. Anurag Tiwari
Email: info@orionmarketreports.com
Contact no: +91 780-304-0404
About Us:
Orion Market Reports (OMR) endeavors to provide an exclusive blend of qualitative and quantitative market research reports to clients across the globe. Our organization helps both multinational and domestic enterprises to bolster their business by providing in-depth market insights and the most reliable future market trends. Our reports address all the major aspects of the markets providing insights and market outlook to global clients.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Imfinzi Market By Size, Demand Analysis, Type, Statistics, Regions and Forecast - 2028 here
News-ID: 2613459 • Views: …
More Releases from Orion Market Reports
![Electronic Films Market Size, Trends, Latest Insights, Analysis and Forecast 2024-2031](https://cdn.open-pr.com/L/8/L801109707_g.jpg)
Electronic Films Market Size, Trends, Latest Insights, Analysis and Forecast 202 …
Global electronic film market is anticipated to grow at a considerable CAGR of 6.0% during the forecast period (2024-2031). Innovations and advancements in the polymer films to make them more compatible in use for several different applications is a major factor promoting the growth of the global electronic films market. For instance, in October 2018, an interdisciplinary team of scientists at the University of Massachusetts Amherst had produced a new…
![Yoga Clothes Market: Embracing Comfort and Style with Projected Growth by 2031](https://cdn.open-pr.com/L/7/L729632715_g.jpg)
Yoga Clothes Market: Embracing Comfort and Style with Projected Growth by 2031
Yoga Clothes Market is experiencing robust growth as more individuals embrace yoga and fitness as part of their lifestyle. Yoga apparel not only offers comfort and flexibility but also reflects personal style, driving its increasing popularity across various demographics. According to recent market research, the Yoga Clothes Market is projected to grow at a compound annual growth rate (CAGR) of 8.2% from 2023 to 2031. Important changes in the business…
![Outbound Medical Tourism Services Market Analysis, Size, Current Scenario and Future Prospects](https://cdn.open-pr.com/L/7/L729731413_g.jpg)
Outbound Medical Tourism Services Market Analysis, Size, Current Scenario and Fu …
Outbound Medical Tourism Services Market is experiencing robust growth as patients seek high-quality, cost-effective medical care across borders. Outbound medical tourism involves traveling from one's home country to another for medical treatments and procedures. According to recent market research, the Outbound Medical Tourism Services Market is projected to grow at a compound annual growth rate (CAGR) of 12.1% from 2023 to 2031. Important changes in the business allow key players…
![B2B Returnable Packaging Market: Enhancing Sustainability and Efficiency in Supply Chains](https://cdn.open-pr.com/L/7/L729123213_g.jpg)
B2B Returnable Packaging Market: Enhancing Sustainability and Efficiency in Supp …
B2B Returnable Packaging Market is experiencing significant growth as businesses seek sustainable and cost-effective packaging solutions. Returnable packaging, designed for multiple uses, helps companies reduce waste, optimize supply chains, and improve overall operational efficiency. According to recent market research, the B2B Returnable Packaging Market is projected to grow at a compound annual growth rate (CAGR) of 6.4% from 2023 to 2031. Important changes in the business allow key players to…
More Releases for SCLC
Small Cell Lung Cancer (SCLC) Therapeutics Market Research & Outlook 2020
Impact Analysis of Coronavirus Disease (Covid-19) on Small Cell Lung Cancer (SCLC) Therapeutics Market
Facto Market Insights published a title on “Small Cell Lung Cancer (SCLC) Therapeutics Market – 2020-2026”, to its collection. The study on the small cell lung cancer (SCLC) therapeutics market defines the analysis of all the segments, along with the market sizing, year-over-year growth analysis and structure of the industry. The research report also includes the analysis…
OpportunityAnalyzer: Small Cell Lung Cancer (SCLC) - Opportunity Analysis and Fo …
Researchmoz added Most up-to-date research on "OpportunityAnalyzer: Small Cell Lung Cancer (SCLC) - Opportunity Analysis and Forecasts to 2024" to its huge collection of research reports.
Initially considered a curable disease due to substantial sensitivity to first-line chemotherapies, small cell lung cancer (SCLC) remains a fatal disease with poor outcomes due to high relapse rates, with the majority of patients surviving one year or less after diagnosis. Unlike non-small cell lung…
Overview of Small cell lung cancer (SCLC) Industry : Market Development, Analysi …
ALBANY, NY, April 5, 2017 : ResearchMoz presents professional and in-depth study of "Small cell lung cancer (SCLC)- Market Insights, Epidemiology and Market Forecast-2023".
DelveInsights Small cell lung cancer (SCLC) - Market Insights, Epidemiology and Market Forecast-2023 Reports provides an overview of the disease and global market trends of the Indication for the seven major markets ie: United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. The Report covers…
Pipeline Analysis Of Small Cell Lung Cancer (SCLC) Market - Insights, Epidemiolo …
ResearchMoz presents this most up-to-date research on "Pipeline Analysis Of Small Cell Lung Cancer (SCLC) Market - Insights, Epidemiology And Forecast To 2023".
DelveInsights Small cell lung cancer (SCLC) - Market Insights, Epidemiology and Market Forecast-2023 Reports provides an overview of the disease and global market trends of the Indication for the seven major markets ie: United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. The Report covers the therapeutics…
Small cell lung cancer (SCLC)- Market Insights, Epidemiology and Market Forecast …
DelveInsights Small cell lung cancer (SCLC) - Market Insights, Epidemiology and Market Forecast-2023 Reports provides an overview of the disease and global market trends of the Indication for the seven major markets ie: United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. The Report covers the therapeutics market revenue; average cost of therapy, treatment practice and Small cell lung cancer (SCLC) forecasted market share for ten years to 2023…
Small Cell Lung Cancer (SCLC) Treatment Market Revenue and Value Chain 2016-2026
According to the World Health Organization (WHO), 8.2 million people died from cancer around the world in 2012, and cancer is now one of the leading causes of death. Lung cancer is the leading cancer type and caused 1.59 million deaths in 2012.
Small cell lung cancer is two types -
Oat cancer
Combiner small cell cancer
The major risk factors for small cell lung…